Company profile for Cascade Chemistry

NEW Drugs in Dev: 2
PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Cascade Chemistry, acquired in June 2021 as a division of Aceto, was founded over 40 years ago by University of Oregon chemistry professor Lloyd Dolby, PhD, as one of the first chemistry outsourcing companies, originally called Organic Consultants. Upon Dr. Dolby’s retirement in 2012, Jeremiah Marsden, PhD, a synthetic chemist on staff, purchased the company. Whether you need help taking your API through synthesis to cGMP ma...
Cascade Chemistry, acquired in June 2021 as a division of Aceto, was founded over 40 years ago by University of Oregon chemistry professor Lloyd Dolby, PhD, as one of the first chemistry outsourcing companies, originally called Organic Consultants. Upon Dr. Dolby’s retirement in 2012, Jeremiah Marsden, PhD, a synthetic chemist on staff, purchased the company. Whether you need help taking your API through synthesis to cGMP manufacturing or want expertise in synthesis or analytical investigation before planning to manufacture elsewhere, Cascade Chemistry is here for you.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
90 North Polk St, Suite 200 Eugene, OR 97402
Telephone
Telephone
+1 5414842387
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20200616005055/en

BUSINESSWIRE
16 Jun 2020

Drugs in Development

read-more
read-more

Details:

Cascade Chemistry has been selected by Renibus Therapeutics, to produce the API for clinical trial supplies of RBT-9, an investigational therapy entering a Phase 2 trial for the treatment of high risk COVID-19 patients.


Lead Product(s): Stannus Protoporphyrin

Therapeutic Area: Infections and Infectious Diseases Brand Name: Undisclosed

Study Phase: Phase IIProduct Type: Miscellaneous

Sponsor: Renibus Therapeutics

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Collaboration June 16, 2020

blank

01

VMX
Not Confirmed
VMX
Not Confirmed

Details : Cascade Chemistry has been selected by Renibus Therapeutics, to produce the API for clinical trial supplies of RBT-9, an investigational therapy entering a Phase 2 trial for the treatment of high risk COVID-19 patients.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Undisclosed

June 16, 2020

blank

Details:

Algernon has made the decision to scale-up cGMP manufacturing of Ifenprodil to support its quickly evolving clinical program for acute lung injury in COVID-19 patients.


Lead Product(s): Ifenprodil Tartrate

Therapeutic Area: Infections and Infectious Diseases Brand Name: Undisclosed

Study Phase: UndisclosedProduct Type: Miscellaneous

Sponsor: Algernon Pharmaceuticals

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Collaboration March 23, 2020

blank

02

VMX
Not Confirmed
VMX
Not Confirmed

Details : Algernon has made the decision to scale-up cGMP manufacturing of Ifenprodil to support its quickly evolving clinical program for acute lung injury in COVID-19 patients.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Undisclosed

March 23, 2020

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty